Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Combination with Metformin

[1] Nathan DM(2009)American Diabetes Association; European Association for Study of Diabetes. Medical Management of Hyperglycemia in Type 2 Diabetes: A consensus algorithm for the initiation and adjustment of therapy Diabetes Care 32 193-203

[2] Buse JB(2009)Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control Endoc Pract 15 540-559

[3] Davidson MB(2012)American Diabetes Association; European Association for Study of Diabetes. Management of hyperglycemia in type 2 diabetes: A patient centered approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Diabetes Care 25 1364-1379

[4] Rodbard HW(2012)Reporting of noninferiority and equivalence randomized trials extension of the CONSORT 2010 statement JAMA 308 2594-2604

[5] Jellinger PS(2012)Initial therapy with the fixed-dose combination of sitagliptin and metformin results in greater improvement in glycaemic control compared with pioglitazone monotherapy in patients with type 2 diabetes Diabetes Obes Metab 14 409-418

[6] Davidson JA(2011)Efficacy and safety of treatment with sitagliptin or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy: a randomized, double-blind, non-inferiority trial Diabetes Obes Metab 13 160-168

[7] Inzucchi SE(2011)One year liraglutide treatment offers sustained and more effective glycaemic control and weight reduction compared with sitagliptin, both in combination with metformin, in patients with type 2 diabetes: a randomized, parallel-group, open-label trial Int J Clin Pract 65 397-407

[8] Bergenstal RM(2010)Efficacy and safety of saxagliptin in combination with metformin compared with sitagliptin in combination with metformin in adult patients with type 2 diabetes mellitus Diabetes Metab Res Rev 26 540-549

[9] Buse JB(2010)Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomized trial Lancet 376 431-439

[10] Piaggio G(2008)Efficacy and safety of sitagliptin when added to ongoing metformin therapy in patients with type 2 diabetes Diabetes Obes Metab 10 959-969

[1] Nathan DM(2009)American Diabetes Association; European Association for Study of Diabetes. Medical Management of Hyperglycemia in Type 2 Diabetes: A consensus algorithm for the initiation and adjustment of therapy Diabetes Care 32 193-203

[2] Buse JB(2009)Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control Endoc Pract 15 540-559

[3] Davidson MB(2012)American Diabetes Association; European Association for Study of Diabetes. Management of hyperglycemia in type 2 diabetes: A patient centered approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Diabetes Care 25 1364-1379

[4] Rodbard HW(2012)Reporting of noninferiority and equivalence randomized trials extension of the CONSORT 2010 statement JAMA 308 2594-2604

[5] Jellinger PS(2012)Initial therapy with the fixed-dose combination of sitagliptin and metformin results in greater improvement in glycaemic control compared with pioglitazone monotherapy in patients with type 2 diabetes Diabetes Obes Metab 14 409-418

[6] Davidson JA(2011)Efficacy and safety of treatment with sitagliptin or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy: a randomized, double-blind, non-inferiority trial Diabetes Obes Metab 13 160-168

[7] Inzucchi SE(2011)One year liraglutide treatment offers sustained and more effective glycaemic control and weight reduction compared with sitagliptin, both in combination with metformin, in patients with type 2 diabetes: a randomized, parallel-group, open-label trial Int J Clin Pract 65 397-407

[8] Bergenstal RM(2010)Efficacy and safety of saxagliptin in combination with metformin compared with sitagliptin in combination with metformin in adult patients with type 2 diabetes mellitus Diabetes Metab Res Rev 26 540-549

[9] Buse JB(2010)Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomized trial Lancet 376 431-439

[10] Piaggio G(2008)Efficacy and safety of sitagliptin when added to ongoing metformin therapy in patients with type 2 diabetes Diabetes Obes Metab 10 959-969